首页> 外文期刊>Medicine. >Acquired von Willebrand Syndrome Associated With Monoclonal Gammopathy: A Single-Center Study of 36 Patients
【24h】

Acquired von Willebrand Syndrome Associated With Monoclonal Gammopathy: A Single-Center Study of 36 Patients

机译:获得性von Willebrand综合征与单克隆丙种球蛋白病相关:36名患者的单中心研究

获取原文
获取外文期刊封面目录资料

摘要

In this single-center retrospective study, we evaluated the accuracy of laboratory tests in diagnosing acquired von Willebrand syndrome associated with lymphoproliferative disorders in 36 consecutive patients diagnosed at the University Hospital of Nantes, France. We also compared hemostatic treatments in the following groups: 21 patients with Waldenstr?m macroglobulinemia (WM), 14 with monoclonal gammopathy of undetermined significance (MGUS) (10 with IgG-MGUS and 4 with IgM-MGUS), and 1 with IgA multiple myeloma (IgA-MM). The diagnosis was made in 18 (50%) patients during systematic screening, in 6 (17%) during active mild hemorrhage, and in 12 (33%) during an active, severe bleed. Of the laboratory tests studied, only closure times measured on the Platelet Function Analyzer (PFA)-100 device reliably diagnosed the hemostatic problem. There was no relationship between the factor VIII activity (FVIII:C) or von Willebrand factor activity (VWF:RCo) levels and the previous history of hemorrhage described by patients. We studied hemostatic treatment in most patients: IgG-MGUS patients responded well to high-dose intravenous immunoglobulin (IVIg) infusions (1 g/kg per d), although patients with IgM-MGUS did not. Desmopressin infusions were effective in 3 patients with IgG-MGUS and 2 patients with IgM-MGUS when the baseline values were above 10 IU/dL, but levels soon returned to the baseline. The 7 WM patients had a good response to desmopressin. These results confirm the efficacy of IVIg in IgG-MGUS patients and the prominent role of closure time in the diagnosis of acquired von Willebrand syndrome. Abbreviations: AVWS = acquired von Willebrand syndrome, CT-ADP = closure time test with ADP cartridge, CT-EPI = closure time test with epinephrine cartridge, DDAVP = desmopressin (1-desamino-8-D-arginine vasopressin), FVIII:C = factor VIII activity, ISTH = International Society on Thrombosis and Haemostasis, IVIg = intravenous immunoglobulin, MG = monoclonal gammopathy, MGUS= monoclonal gammopathy of undetermined significance, MM = multiple myeloma, PFA = Platelet Function Analyzer, VWF = von Willebrand factor, VWF:Ag = Von Willebrand factor antigen, VWF:RCo = von Willebrand factor activity, WM = Waldenstr?m macroglobulinemia.
机译:在这项单中心回顾性研究中,我们评估了在法国南特大学医院连续诊断的36例患者中,实验室检查在诊断与淋巴增生性疾病相关的后天性von Willebrand综合征的准确性。我们还比较了以下几组的止血治疗:21例Waldenstr?m巨球蛋白血症(WM),14例具有未确定意义的单克隆丙种球蛋白病(MGUS)(10例IgG-MGUS和4例IgM-MGUS)以及1例IgA多骨髓瘤(IgA-MM)。在系统性筛查期间,有18例(50%)患者被诊断出来,在活动性轻度出血中有6例(17%),在活动性严重出血中有12例(33%)。在所研究的实验室测试中,只有在血小板功能分析仪(PFA)-100设备上测量的闭合时间才能可靠地诊断出止血问题。 VIII因子活性(FVIII:C)或von Willebrand因子活性(VWF:RCo)水平与患者描述的先前出血史之间没有关系。我们研究了大多数患者的止血疗法:IgG-MGUS患者对大剂量静脉注射免疫球蛋白(IVIg)输注(1 g / kg / d)的反应良好,尽管IgM-MGUS患者没有。当基线值高于10 IU / dL时,去氨加压素输注对3例IgG-MGUS患者和2例IgM-MGUS患者有效,但很快就恢复到基线水平。 7名WM患者对去氨加压素反应良好。这些结果证实了IVIg在IgG-MGUS患者中的功效以及闭合时间在诊断获得性von Willebrand综合征中的重要作用。缩写:AVWS =后天性von Willebrand综合征,CT-ADP =用ADP药筒关闭时间测试,CT-EPI =用肾上腺素药盒关闭时间测试,DDAVP =去氨加压素(1-desamino-8-D-精氨酸血管加压素),FVIII:C = VIII因子活性,ISTH =国际血栓形成和止血协会,IVIg =静脉注射免疫球蛋白,MG =不确定的单克隆丙种球蛋白病,MGUS =未确定意义的单克隆丙种球蛋白病,MM =多发性骨髓瘤,PFA =血小板功能分析仪,VWF = von Willebrand因子,VWF :Ag = Von Willebrand因子抗原,VWF:RCo = von Willebrand因子活性,WM =巨球蛋白血症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号